Mann Best Paper Award finalists for the best articles published in the Volume. Wang, Abdurrahman Abdurrob, Julia Spoendlin et al.
International Conference on Pharmacoepidemiology 12222
Volume 27, Issue 4. Brophy Volume 27, Issue 1. Comparative effectiveness and safety of antiplatelet drugs in patients with diabetes mellitus and acute coronary syndrome Julia Spoendlin, Joshua J. Gagne, Jennifer J.
Pharmacoepidemiology and Pharmacovigilance - 1st Edition
Lewey et al. Volume 27, Issue Members, be sure to receive your free online access to the journal.
- Introduction to Probability Simulation and Gibbs Sampling with R!
- PharmaLex | International Conference on Pharmacoepidemiology - PharmaLex?
- Pharmacoepidemiology & Pharmacoeconomics Research?
- Pharmacoepidemiology | Epidemiology, Biostatistics and Occupational Health - McGill University.
Join ISPE today to gain journal access tomorrow. More details for the event can be found here.
The following is a list of the most cited articles based on citations published in the last three years, according to CrossRef. If you do not receive an email within 10 minutes, your email address may not be registered, and you may need to create a new Wiley Online Library account.
If the address matches an existing account you will receive an email with instructions to retrieve your username. Skip to Main Content. Journal list menu Journal. Pharmacoepidemiology and Drug Safety.
Edited By: B. Strom, USA; V. Leufkens, The Netherlands; B.
Park, Korea. Impact factor: 2.
Online ISSN: Brophy Volume 27, Issue 1 Comparative effectiveness and safety of antiplatelet drugs in patients with diabetes mellitus and acute coronary syndrome Julia Spoendlin, Joshua J. On the Cover Skip slideshow. The cover image, by Yinghui Duan et al.
The cover image, by Tetsu Kobayashi et al. The cover image, by Alfred Daniel Mahr et al. Acton Allison W. Willis Michael A. Gelfand Scott E.
Open access. Important secondary themes include patterns of utilization and adherence, safety signal detection, comparative effectiveness, and cost-benefit and benefit-risk analyses. Training in the Program in Pharmacoepidemiology focuses on the application of pharmacoepidemiologic design and analysis methods and causal thinking to address important clinical questions in real-world data. Courses cover such areas as pharmacoepidemiology, database analytics, propensity scores, comparative effectiveness, clinical trials, decision sciences, and health services research.
Students have the opportunity to participate in ongoing research projects with associated faculty. Students are also encouraged to engage with the broader field of pharmacoepidemiology outside the school and to undertake internships in regulatory agencies or pharmaceutical and biotechnology companies. The mission of the Program in Pharmacoepidemiology is to: 1 advance research in the determinants of both intended and unintended effects of drugs, vaccines, biologics, medical procedures, and medical devices; 2 train the next generation of leaders who will continue to advance the field; and 3 enhance research and academic capacity in pharmacoepidemiology.
Skip to content Program in Pharmacoepidemiology. Harvard T.